Skip to main content
SpringerLink
Log in

Prophylaxe der venösen Thrombose

  • Chapter
Hämostaseologie

  • 19 Accesses

Zusammenfassung

Thromboembolische Ereignisse stellen eine schwerwiegende Komplikation in der chirurgischen und inneren Medizin dar. Die tödliche Lungenembolie entsteht bei etwa 3% der Patienten nach Hüftgelenkersatz, bei 0,1–6% der Patienten in der Abdominalchirurgie bis hin zu 8% bei ausgedehnten Amputationen der unteren Extremität und bei 1–5% der Patienten mit internistischen Erkrankungen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

Literatur

  • Abernethy EE, Hartsuck J (1974) Postoperative pulmonary embolism: A prospective study utilizing low-dose heparin. Am J Surg 128:739–742

    Article  PubMed  CAS  Google Scholar 

  • Antiplatelet Trialists’ Collaboration Group (1994) Collaborative overview of randomized trials of antiplatelet therapy III: Reduction of venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. Br Med J 308:235–246

    Article  Google Scholar 

  • Ballard RM, Bradley-Watson PJ, Johnstone FD et al. (1973) Low doses of subcutaneous heparin in the prevention of deep vein thrombosis after gynecological surgery. J Obstet Gynecol Br Commonw 80:469–475

    Article  CAS  Google Scholar 

  • Bergmann JF, Neuhardt E (1996) A multicenter randomized double-blind study of Enoxaparin compared with unfrac-tionated heparin in the prevention of venous thromboembolic disease in elderly in-patients bedridden for an acute medical illness. Thromb Haemost 76:529–534

    PubMed  CAS  Google Scholar 

  • Bergqvist D (1997) New approaches to prevention of deep-vein thrombosis. Thromb Haemost 78:684–688

    PubMed  CAS  Google Scholar 

  • Bergqvist D, Burmark US, Frisell J et al. (1986) Low molecular weight heparin once daily compared with conventional low dose heparin twice daily: A prospective double-blind multicentre trial on prevention of postoperative thrombosis. Br J Surg 73:204–208

    Article  PubMed  CAS  Google Scholar 

  • Bergqvist D, Mätzsch T, Burmark US et al. (1988) Low molecular weight heparin given the evening before surgery compared with conventional low dose heparin in prevention of thrombosis. Br J Surg 75:888–891

    Article  PubMed  CAS  Google Scholar 

  • Bergqvist D, Kettunen K, Fredin H et al. (1991) Thromboprophylaxis in hip fracture patients — A prospective randomized comparative study between ORG 10172 and dextran. Surgery 109:617–624

    PubMed  CAS  Google Scholar 

  • Bergqvist D, Benoni G, Bjorgell O et al. (1996) Low molecular weight heparin (Enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement. N Engl J Med 335:696–700

    Article  PubMed  CAS  Google Scholar 

  • Borgstrom S, Greitz T, Vander Linden W et al. (1965) Anticoagulant prophylaxis of venous thrombosis in patients with fractured neck of the femur: A controlled clinical trial using venous phlebography. Acta Chir Scand 129:500–508

    Google Scholar 

  • Caen JO (1988) A randomized double-blind study between a low molecular weight heparin Kabi 2165 and standard heparin in the prevention of deep vein thrombosis in general surgery. Thromb Haemost 59:216–220

    PubMed  CAS  Google Scholar 

  • Clagett GP, Anderson FA, Heit J et al. (1995) Prevention of venous thromboembolism. Chest 108(Suppl):313S–334S

    Google Scholar 

  • Cook DJ, Guyatt GH, Laupacis A et al. (1995) Clinical recommendations using levels of evidence for antithrombotic agents. Chest 108:227S–230S

    Article  PubMed  CAS  Google Scholar 

  • Covey TH, Sherman L, Baue E (1975) Low dose heparin in postoperative patients. Arch Surg 110:1021–1028

    Article  PubMed  CAS  Google Scholar 

  • Czechanowski B, Heinrich F (1981) Prophylaxe venöser Thrombosen bei frischem ischämischen zerebrovaskulä-ren Insult. Doppelblindstudie mit Heparin-Dihydergot. Dtsch Med Wochenschr 106:1254–1260

    Article  PubMed  CAS  Google Scholar 

  • Dahan R, Houlbert D, Caulin C et al. (1986) Prevention of deep vein thrombosis in elderly medical patients by a low molecular weight heparin: A randomized double-blind trial. Haemostasis 16:159–168

    PubMed  CAS  Google Scholar 

  • Dahl OE, Andreassen G, Aspelin T et al. (1997) Prolonged thromboprophylaxis after hip replacement surgery — results of a double-blind prospective, randomized, placebo-controlled study with Dalteparin (Fragmin). Thromb Haemost 77:26–31

    PubMed  CAS  Google Scholar 

  • Danish Enoxaparin Study Group (1991) Low-molecular-weight heparin (Enoxaparin) vs dextran 70. The prevention of postoperative deep vein thrombosis after total hip replacement. Arch Intern Med 151:1621–1626

    Article  Google Scholar 

  • Dechavanne M, Saudin F, Viala JJ et al. (1974) Prevention des thromboses veineuses: Succes de l’ heparine a fortes doses lors des Coxarthrose. Nouv Presse Med 3:1317–1319

    PubMed  CAS  Google Scholar 

  • Dechavanne M, Ville D, Berruyer M et al. (1989) Randomized trial of a low-molecular-weight heparin (Kabi 2165) versus adjusted dose subcutaneous standard heparin in the prophylaxis of deep-vein thrombosis after elective hip surgery. Haemostasis 19:5–12

    PubMed  CAS  Google Scholar 

  • Emerson PA, Marks P (1977) Preventing thromboembolism after myocardial infarction: effect of low-dose heparin on smoking. Brit Med J 1:18–20

    Article  PubMed  CAS  Google Scholar 

  • Encke A, Breddin KH (1988) Comparison of a low molecular weight heparin and unfractionated heparin for the prevention of deep vein thrombosis in patients undergoing abdominal surgery. Br J Surg 75:1058–1063

    Article  Google Scholar 

  • Eriksson BI, Kalebo P, Anthmyr BA et al. (1991) Prevention of deep vein thrombosis and pulmonary embolism after total hip replacement. J Bone Joint Surg 73A:484–493

    Google Scholar 

  • Eriksson BI, Ekman S, Kalebo P et al. (1996) Prevention of deep vein thrombin after total hip replacement: direct thrombosis inhibition with recombinant hirudin, CGP 39393. Lancet 347:635–639

    Article  PubMed  CAS  Google Scholar 

  • Eriksson BI, Wille-Jorgensen P, Kalebo P et al. (1997) A comparison of recombinant hirudin with a low-molecular-weight heparin to prevent thromboembolic complications after total hip replacement. N Engl J Med 337:1329–1335

    Article  PubMed  CAS  Google Scholar 

  • Eskeland G, Solheim K, Skorten F (1966) Anticoagulant prophylaxis, thromboembolism and mortality in elderly patients with hip fractures: A controlled clinical trial. Acta Chir Scand 131:16–24

    PubMed  CAS  Google Scholar 

  • Estoppey D, Hochreiter J, Breyer HG et al. (1989) ORG 10172 (Lomoparin) versus heparin-DHE in prevention of thromboembolism in total hip replacement — A multicentre trial. Thromb Haemost 62:356–362

    Google Scholar 

  • Francis CW, Meyer D, Roberts E et al. (1983) Two-step warfarin therapy: Prevention of postoperative venous thrombosis without excessive bleeding. JAMA 249:374–378

    Article  PubMed  CAS  Google Scholar 

  • Freeark KA, Boswick J, Fardin R (1967) Posttraumatic venous thrombosis. Arch Surg 95:567–575

    Article  PubMed  CAS  Google Scholar 

  • Fricker JP, Vergnes Y, Schach R et al. (1988) Low dose heparin versus low molecular weight heparin Kabi 2165 in the prophylaxis of thromboembolic complications of abdominal oncological surgery. Eur J Clin Invest 18:561–572

    Article  PubMed  CAS  Google Scholar 

  • Gallus AS, Hirsh J, Tuttle RJ et al. (1973) Small subcutaneous doses of heparin in prevention of venous thrombosis. N Engl J Med 288:545–551

    Article  PubMed  CAS  Google Scholar 

  • Gallus AS, Hirsh J, O’ Brien SE et al. (1975) Prevention of venous thrombosis with small subcutaneous doses of heparin. JAMA 235:980–989

    Google Scholar 

  • Geerts WH, Code KJ, Jay RM et al. (1994) A prospective study of venous thromboembolism after major trauma. N Engl J Med 331:1601–1606

    Article  PubMed  CAS  Google Scholar 

  • Geerts WH, Jay RM, Code KJ et al. (1996) A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma. N Engl J Med 335:701–717

    Article  PubMed  CAS  Google Scholar 

  • GHAT Group (1992) Prevention of deep vein thrombosis with low molecular-weight heparin in patients undergoing total hip replacement. A randomized trial. Arch Orthop Trauma Surg 111:110–120

    Article  Google Scholar 

  • Gibbert FB, Gould SR, Marks P (1976) Incidence of deep vein thrombosis and leg oedema in patients with stroke. J Neurol Neurosurg Psychiatr 39:1222–1225

    Article  Google Scholar 

  • Gordon-Smith IC, Le Queste LP, Grundy DJ, Newcombe JF (1972) Controlled trial of two regimens of subcutaneous heparin in prevention of postoperative deep-vein thrombosis. Lancet 1:1133–1135

    Article  PubMed  CAS  Google Scholar 

  • Green D, Lee MY, Lim AC et al. (1990) Prevention of thromboembolism after spinal cord injury using low molecular weight heparin. Ann Intern Med 113:571–574

    Article  PubMed  CAS  Google Scholar 

  • Groote Schuur Hospital Thromboembolus Study Group (1979) Failure of low-dose heparin to prevent significant thromboembolic complications in high-risk surgical patients: interim report of prospective trial. Br Med J 1:1447–1450

    Article  Google Scholar 

  • Gruber UF, Duckert F, Fridrich R et al. (1977) Prevention of postoperative thromboembolism by dextran 40, low doses of heparin, or xantional nicotinate. Lancet 1:207–214

    Article  PubMed  CAS  Google Scholar 

  • Haas S (1996) Risikoabschätzung thromboembolischer Komplikationen bei chirurgischen Erkrankungen und Verletzungen. Akt Chir 31:269–274

    Google Scholar 

  • Hamilton HW, Crawford JS, Gardiner JH, Wiley AM (1970) Venous thrombosis in patients with fracture of the upper end of the femur. J Bone Joint Surg 52B:268–274

    Google Scholar 

  • Hampson WGJ, Harris PC, Lucas HK et al. (1974) Failure of low-dose heparin to prevent deep-vein thrombosis after hip replacement arthroplasty. Lancet 11:795–789

    Article  Google Scholar 

  • Handley AJ (1972) Low dose heparin after myocardial infarction. Lancet 11:623–624

    Article  Google Scholar 

  • Harenberg J, Schmitz-Huebner U (1997) Therapie der Beinvenenthrombose mit niedermolekularen Heparinen. Dt Ä rztebl 94:A-2257, B-1837, C-1703

    Google Scholar 

  • Harenberg J, Kallenbach B, Martin U et al. (1990) Randomized controlled study of heparin and low molecular weight heparin for prevention of deep-vein thrombosis in medical patients. Thromb Res 59:639–650

    Article  PubMed  CAS  Google Scholar 

  • Harenberg J, Roebruck P, Heene DL (1996) Subcutaneous low-molecular-weight heparin versus standard heparin for prevention of thromboembolism in medical in-patients. Haemostasis 26:127–139

    PubMed  CAS  Google Scholar 

  • Hartle P, Brucke P, Dienstl E, Vinazzer H (1990) Prophylaxis of thromboembolism in general surgery: Comparison between standard heparin and Fragmin. Thromb Res 57:577–584

    Article  Google Scholar 

  • Heit J, Kessler C, Mammen E et al. for the RD Heparin Study Group (1991) Efficacy of RD heparin (a LMWH) and warfarin for prevention of deep-vein thrombosis after hip or knee replacement. Blood 72:831–840

    Google Scholar 

  • Hume M, Kuriakose T, Xavier ZI, Turner RH (1973) 125I-fibrinogen and the prevention of venous thrombosis. Arch Surg 107:803–812

    Article  PubMed  CAS  Google Scholar 

  • International Multicentre Trial (1975) Prevention of fatal postoperative pulmonary embolism by low doses of heparin. Lancet 11:45–51

    Google Scholar 

  • Kakkar VV, Murray WJG (1985) Efficacy and safety of low molecular weight heparin (CY216) in preventing postoperative venous thromboembolism. Br J Surg 72:786–791

    Article  PubMed  CAS  Google Scholar 

  • Kakkar VV, Spindler J, Flute PT et al. (1972) Efficacy of low-doses of heparin in prevention of deep-vein thrombosis after major surgery: A double-blind randomized trial. Lancet 11:101–106

    Article  Google Scholar 

  • Keser C, Groh J, Schramm W, Peter K (1997) Thromboembolieprophylaxe mit Heparinen: Gefahr bei rückenmarknaher Anästhesie? Heparin 11:1–6

    Google Scholar 

  • Koppenhagen K (1997) Empfehlungen zur stationären und ambulanten Thromboembolie-Prophylaxe in der Chirurgie. Expertengespräch zur Thromboembolie-Prophylaxe. Mitteilungen der Deutschen Gesellschaft für Chirurgie 5, Demeter

    Google Scholar 

  • Kudsk KA, Fabian TC, Baum S et al. (1989) Silent deep vein thrombosis in immobilized multiple trauma patients. Am J Surg 158:515–519

    Article  PubMed  CAS  Google Scholar 

  • Lahnborg G, Friman L, Bergstrom K, Lagergren H (1974) Effect of low-dose heparin on incidence of postoperative pulmonary embolism detected by photoscanning. Lancet 1:329–331

    Article  PubMed  CAS  Google Scholar 

  • Lassen M, Borris L (1995) Prolonged thromboprophylaxis with low molecular weight heparin (Fragmin) after elective total hip arthroplasty -’ a placebo controlled study. Thromb Haemost 73:1104

    Google Scholar 

  • Lechler E, Schramm W, Flosbach CW (1996) The venous thrombotic risk in non-surgical patients: epidemiological data and efficacy/safety profile of a low-molecular-weight heparin (Enoxaparin). The Prime Study Group. Haemostasis 26 (Suppl 2):49–56

    PubMed  CAS  Google Scholar 

  • Leizorovicz A, Picolet H, Peyrieux JC, Boissel JP (1991) Prevention of perioperative deep vein thrombosis in general surgery: A multicentre double-blind study comparing two doses of logiparin and standard heparin. Br J Surg 78:412–416

    Article  Google Scholar 

  • Leizorovicz A, Haugh MC, Chapuis FR et al. (1992) Low molecular weight heparin in the prevention of perioperative thrombosis. Br Med 305:913–920

    Article  CAS  Google Scholar 

  • Levine MN, Hirsh J, Gent et al. (1991) Prevention of deep vein thrombosis after elective hip surgery: A randomized trial comparing low molecular weight heparin with standard unfractionated heparin. Ann Intern Med 114:545–551

    Article  PubMed  CAS  Google Scholar 

  • Leyvraz PF, Bachmann F, Hoek J et al. (1991) Prevention of deep vein thrombosis after hip replacement: Randomized comparison between unfractionated heparin and low molecular weight heparin. Br Med J 303:543–548

    Article  CAS  Google Scholar 

  • Mannucci PM, Citterio LA, Penajotopoulos N (1976) Low-dose heparin and deep vein thrombosis after total hip replacement. Thromb Haemost 36:157–164

    PubMed  CAS  Google Scholar 

  • Mätzsch T, Bergqvist D, Fredin H et al. (1991) Comparison of the thromboprophylactic effect of low molecular weight heparin versus dextran in total hip replacement. Thromb Haemorrh Disorders 3:25–29

    Google Scholar 

  • McCarthy ST, Robertsson D, Turner JJ, Hawkey CJ (1977) Low-dose heparin as a prophylaxis against deep-vein thrombosis after acute stroke. Lancet 11:800–801

    Article  Google Scholar 

  • Molnar L, Demeter I, Vamosi B, Csornai M (1981) Phlebothrombose der unteren Extremitäten bei Kranken mit Hemiplegie nach zerebralem Insult. Folia Angiol 29:16–19

    Google Scholar 

  • Morris GK, Mitchell JR (1975) Warfarin sodium in the prevention of deep venous thrombosis and pulmonary embolism in patients with fractured neck of femur. Lancet 11:869–871

    Google Scholar 

  • Morris GK, Henry APJ, Preston BJ (1974) Prevention of deep-vein thrombosis by low-dose heparin in patients undergoing total hip replacement. Lancet 11:797–801

    Article  Google Scholar 

  • Moskovitz PA, Ellenberg SS, Feffer HL et al. (1978) Low dose heparin for prevention of venous thromboembolism in total hip arthroplasty and surgical repair of hip fractures. J Bone Joint Surg 60:1065–1070

    PubMed  CAS  Google Scholar 

  • Nicolaides AN, Dupont PA, Desais S et al. (1972) Small doses of subcutaneous sodium heparin in preventing deep venous thrombosis after major surgery. Lancet 11:890–893

    Article  Google Scholar 

  • Nurmohamed MT, Rosendaal FR, Büller HR et al. (1991) Low molecular weight heparin versus Standard heparin in general and orthopaedic surgery: a meta-analysis. Lancet 340:152–155

    Article  Google Scholar 

  • Nylander G, Semb H (1972) Veins of the lower limb after tibial fractures. Surg Gynecol Obstet 134:974–977

    PubMed  CAS  Google Scholar 

  • Pezzuoli G, Neri Serneri GG, Settembrini P et al. (STEP-Study Group) (1989) Prophylaxis of fatal pulmonary embolism in general surgery using low molecular weight heparin CY 216: A multicentre double-blind randomized controlled clinical trial versus placebo. Int Surg 74:205–214

    PubMed  CAS  Google Scholar 

  • Pinto DJ (1970) Controlled trial of an anticoagulant (warfarin sodium) in the prevention of venous thrombosis following hip surgery. Br J Surg 57:349–354

    Article  PubMed  CAS  Google Scholar 

  • Planes A, Vochelle N, Mazas F et al. (1988) Prevention of postoperative venous thrombosis: A randomized trial comparing unfractionated heparin with low molecular weight heparin in patients undergoing total hip replacement. Thromb Haemost 60:407–410

    PubMed  CAS  Google Scholar 

  • Planes A, Vochelle N, Darmon JY et al. (1996) Risk of deep-venous thrombosis after hospital discharge in patients having undergone total hip replacement: double-blind randomized comparison of Enoxaparin versus placebo. Lancet 348:224–228

    Article  PubMed  CAS  Google Scholar 

  • Prasad BK, Banerjee AK, Howard H (1982) Incidence of deep vein thrombosis and effect of pneumatic compression of the calf in elderly hemiplegics. Age Ageing 11:42–44

    Article  PubMed  CAS  Google Scholar 

  • Prins MH, Gelsema R, Sing AK, van Heerala LR, Ottolander GJH (1989) Prophylaxis of deep venous thrombosis with a low-molecular-weight heparin (Kabi 2165/Fragmin) in stroke patients. Haemostasis 19:245–250

    PubMed  CAS  Google Scholar 

  • Rem J, Duckert F, Fridrich R, Gruber UF (1975) Subkutane kleine Heparindosen zur Thromboseprophylaxe in der allgemeinen Chirurgie und Urologie. Schweiz Med Wo-chenschr 105:827–832

    CAS  Google Scholar 

  • Roise OM, Nurmohamed M, Reijnders P et al. (1993) A multicentre, randomised, assessor-blind, pilot study comparing the efficacy in the prophylaxis of DVT and the safety of Orgaran® (ORG 10172), Fragmin®, Clexane®/Love-nox® in patients undergoing surgery for a fractured hip. Thromb Haemost 69:273 (Abstract)

    Google Scholar 

  • Rosenberg IL, Evans M, Pollock AV (1975) Prophylaxis of postoperative leg vein thrombosis by low-dose subcutaneous heparin or preoperative calf muscle stimulation. A controlled clinical trial. Br Med J 1:649–651

    Article  PubMed  CAS  Google Scholar 

  • Samama M, Bernard P, Bonnardot JP et al. (1988) Low molecular weight heparin compared with unfractionated heparin in prevention of postoperative thrombosis. Br J Surg 75:128–134

    Article  PubMed  CAS  Google Scholar 

  • Scottish Study (1974) A multi-unit controlled trial: heparin versus dextran in the prevention of deep-vein thrombosis. Lancet 11:118–124

    Google Scholar 

  • Sevitt S, Gallagher NG (1959) Prevention of venous thrombosis and pulmonary embolism in injured patients: a trial of anticoagulant prophylaxis with phenindione in middle-aged and elderly patients with fractured necks of femur. Lancet 11:981–989

    Article  Google Scholar 

  • Sevitt S, Gallagher N (1961) Venous thrombosis and pulmonary embolism: a clinicopathologic study in injured and burned patients. Br J Surg 45:475–489

    Article  Google Scholar 

  • Sharnoff JG (1966) Results in the prophylaxis of postoperative thromboembolism. Surg Gynecol Obstet 123:303–307

    PubMed  CAS  Google Scholar 

  • Spiro TE, Enoxaparin Clinical Trials Group (1991) A randomized trial of enoxaparin administered postoperatively for the prevention of deep vein thrombosis following elective hip replacement. Thromb Haemost 65:824 (Abstract)

    Google Scholar 

  • Taberner DA, Poller L, Burslem RW, Jones JB (1978) Oral anticoagulants controlled by the British comparative thromboplastin versus low-dose heparin in prophylaxis of deep vein thrombosis. Br Med J 1:272–274

    Article  PubMed  CAS  Google Scholar 

  • Turpie AGG, Levine MN, Hirsh J et al. (1987) A double-blind randomized trial of ORG 10172 low molecular weight heparinoid in the prevention of deep vein thrombosis in thrombotic stroke. Lancet 1:523–526

    Article  PubMed  CAS  Google Scholar 

  • Turpie AGG, Levine MN, Powers PJ et al. (1991) A double-blind randomized trial of ORG 10172 low molecular weight heparinoid versus unfractionated heparin in the prevention of deep vein thrombosis in patients with thrombotic stroke. Thromb Haemost 65:753–761

    Google Scholar 

  • Venous Thrombosis Study Group (1975) Small doses of subcutaneous sodium heparin in the prevention of deep vein thrombosis after elective hip operation. Br J Surg 62:348–352

    Article  Google Scholar 

  • Warlow C, Ogston D, Douglas AS (1972) Venous thrombosis following strokes. Lancet 1:1305–1306

    Article  PubMed  CAS  Google Scholar 

  • Warlow C, Beattie AG, Terry G et al. (1973) A double blind trial of low doses of subcutaneous heparin in the prevention of deep vein thrombosis after myocardial infarction. Lancet 11:934–936

    Article  Google Scholar 

  • Warlow C, Ogston D, Douglas AS (1976) Deep vein thrombosis of the legs after strokes. Br Med J 1:1178–1183

    Article  PubMed  CAS  Google Scholar 

  • Willen J, Bergqvist D, Hallbrook T (1982) Venous insufficiency as a late complication of tibial fracture. Acta Orthop Scand 53:149–153

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. J. Harenberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Haas
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K. H. Breddin
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Kerckhoff-Klinik, Abteilung Hämostaseologie und Transfusionsmedizin, Max-Planck-Institut für physiologische und klinische Forschung, Sprudelhof 11, D-61231, Bad Nauheim, Deutschland

    Gert Müller-Berghaus  & Bernd Pötzsch  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Harenberg, J., Haas, S., Breddin, K.H. (1999). Prophylaxe der venösen Thrombose. In: Müller-Berghaus, G., Pötzsch, B. (eds) Hämostaseologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-07673-6_79

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-07673-6_79

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-07674-3

  • Online ISBN: 978-3-662-07673-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation